Press Releases

Ceapro Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

September 14, 2020

Ceapro Inc. Reports 2020 Second Quarter and Six-Month Financial Results and Operational Highlights

August 20, 2020

Ceapro Inc. Provides Update on Development of an Inhalable Therapeutic for COVID-19

August 18, 2020

Ceapro Inc. Announces Publication of Positive Results from Study Evaluating Avenanthramides in Exercise-Induced Inflammation

August 4, 2020

Ceapro Announces Results of 2020 Shareholders’ Meeting

June 22, 2020

Ceapro Inc. Announces Publication of Positive Results for a PGX Processed Drug Delivery System for Accelerated Burn Wound Healing

June 15, 2020

Ceapro Inc. to Present at the Virtual Investor Fireside Chat Series

June 9, 2020

Ceapro Inc. Reports 2020 First Quarter Financial Results and Highlights

May 28, 2020

Ceapro Inc. Expands Collaborative Research Program with McMaster University to Develop Inhalable Therapeutic for COVID-19

May 26, 2020

Ceapro Inc. Reports Fourth Quarter and Full Year 2019 Results and Highlights

April 16, 2020

1
2
3
4
5
6
7
8
9
10
...21
Next »